Regulation of retinal hemodynamics in diabetic rats by increased expression and action of endothelin-1

Investigative Ophthalmology and Visual Science

Volumn 37, Issue 12, 1996, Pages 2504-2518

  Takagi, Chikako ^a   Bursell, Sven Erik ^a   Lin, You Wei ^a   Takagi, Hitoshi ^a   Duh, Elia ^a   Jiang, Zhen ^a   Clermont, Allen C ^a   King, George L ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b JOSLIN DIABETES CENTER   (United States)

Author keywords

diabetes; endothelin; endothelin receptor; endothelin converting enzyme; retinal hemodynamics

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN RECEPTOR ANTAGONIST; SARALASIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL TONE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DOSE RESPONSE; HEMODYNAMIC MONITORING; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; RAT; RETINA BLOOD FLOW; TREATMENT OUTCOME;

ANIMALS; BRAIN; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; DNA PRIMERS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIN-1; ENDOTHELINS; FLUORESCEIN ANGIOGRAPHY; GLYCOPEPTIDES; HEMODYNAMIC PROCESSES; MALE; METALLOENDOPEPTIDASES; PEPTIDES, CYCLIC; POLYMERASE CHAIN REACTION; PROTEASE INHIBITORS; PROTEIN PRECURSORS; RATS; RATS, INBRED BN; RATS, SPRAGUE-DAWLEY; RECEPTORS, ENDOTHELIN; RETINA; RETINAL VESSELS; RNA, MESSENGER;

EID: 0029846720     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Kuwabara T, Cogan DG. Retinal vascular patterns VI. Mural cells of the retinal capillaries. Arch Ophthalmol. 1963;69:492-502.
2. King GL, Banskota NK. Mechanism of diabetic micro vascular complications. In: Kahn CR, Weir GC, eds. Joslin's Diabetes Mellitus. 13th ed. Philadelphia: Lea & Febiger; 1994:631-647.
3. Bursell S-E, Clemont AC, Oren B, King GL. The in vivo effect of endothelin on retinal circulation in non-diabetic and diabetic rats. Invest Ophthalmol Vis Sci. 1995;36:596-607.
4. Takagi C, King GL, Clermont AC, Cummins DR, Takagi H, Bursell S-E. Reversal of abnormal retinal hemodynamics in diabetic rats by acarbose, an α-glucosidase inhibitor. Curr Eye Res. 1995;14:741-749.
5. Clermont AC, Brittis M, Shiba T, McGovern T, King GL, Bursell S-E. Normalization of retinal blood flow in diabetic rats with primary intervention using insulin pumps. Invest Ophthalmol Vis Sci. 1994;35:981-990.
6. Shiba T, Inoguchi T, Sportsman JR, Heath WF, Bursell S-E, King GL. Correlation of diacylglycerol level and protein kinase C activity in rat retina to retinal circulation. Am J Physiol. 1993;265:E783-E793.
7. Grunwald JE, Riva CE, Sinclai SH, Brucker AJ, Petrig BL. Laser Doppler velocimetry study of retinal circulation in diabetes mellitus. Arch Ophthalmol. 1986; 104:991-996.
8. Kohner EM, Patel V, Rassam SM. Role of blood flow and impaired autoregulation in the pathogenesis of diabetic retinopathy. Diabetes. 1995;44:603-607.
9. Blair NP, Feke GT, Morales-Stoppello J, et al. Prolongation of retinal mean circulation time in diabetes. Arch Ophthalmol. 1982;100:764-768,
10. Bertram B, Wolf S, Fiehofer S, Schulte K, Arend O, Reim M. Retinal circulation times in diabetes mellitus Type I. Br J Ophthalmol. 1991;75:462-465.
11. Wolf S, Arend O, Toonen H, Bertram B, Reim M. Measurement of retinal micro and macrocirculation in patients with diabetes mellitus with scanning laser ophthalmoscopy. Clin Vis Sci. 1992;7:461-469.
12. Bursell S-E, Clermont AC, Kinsley BT, Simonson DC, Aiello LM, Wolpert HA. Retinal blood flow changes in patients with insulin dependent diabetes mellitus and no diabetic retinopathy: A video fluorescein angiography study. Invest Ophthalmol Vis Sci. 1996;37:886-897.
13. Arend O, Wolf S, Jung F, Bertram B, Postgens HT, Reim M. Retinal microcirculation in patients with diabetes mellitus: Dynamic and morphological analysis of perifoveal capillary network. Br J Ophthalmol. 1991;75:514-518.
14. Kawagishi T, Nishizawa Y, Emoto M, et al. Impaired retinal artery blood flow in IDDM patients before clinical manifestations of diabetic retinopathy. Diabetes Care. 1995;18:1544-1549.
15. Miyamoto K, Ogura Y, Nishiwaki H, et al. Evaluation of retinal microcirculatory alterations in the Goto-Kakizi rat: A spontaneous model for non-insulin dependent diabetes. Invest Ophthalmol Vis Sci. 1996;37:898-905.
16. Feke GT, Buzney SM, Ogasawara H, et al. Retinal circulatory abnormalities in Type I Diabetes. Invest Ophthalmol Vis Sci. 1994;35:2968-2975.
17. Konno S, Feke GT, Yoshida A, Fujio N, Goger DG, Buzney SM. Retinal blood flow changes in Type I diabetes: A long-term follow-up study. Invest Ophthalmol Vis Sci. 1996;37:1140-1148.
18. Zatz R, Brenner B. Pathogenesis of diabetic microangiopathy: The hemodynamic review. Am J Med. 1986;80:443-453.
19. De la Rubia G, Oliver FJ, Inoguchi T, King GL. Induction of resistance to endothelin-1's biochemical actions by elevated glucose levels in retinal pericytes. Diabetes. 1992;41:1533-1539.
20. Takahashi K, Brooks RA, Kanse SM, Ghatei MA, Kohner EM, Bloom SR. Production of endothelin-1 by cultured bovine retinal endothelial cells and presence of endothelin receptors on associated pericytes. Diabetes. 1989;38:1200-1202.
21. Bohlen HG, Lash JM. Topical hyperglycemia rapidly suppresses EDRF-mediated vasodilation of normal rat arterioles. Am J Physiol. 1993;265:H219-H225.
22. Langenstroer P, Pieper GM. Regulation of spontaneous EDRF release in diabetic rat aorta by oxygen free radicals. Am J Physiol. 1992;263:H257-H265.
23. Steel M, Nolan C, Nankervis A, et al. Forearm arterial vascular responsiveness in insulin-dependent diabetic subjects. Diabetes Res Clin Pract. 1993;21:127-136.
24. Tesfamariam B, Brown ML, Cohen RA. 15-Hydroxyeicosatetraenoic acid and diabetic endothelial dysfunction in rabbit aorta. J Cardiovasc Pharmacol. 1995;25:748-755.
25. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332:411-415.
26. Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature. 1990;348:730-732.
27. Sakurai T, Yanagisawa M, Takuwa Y, et al. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature. 1990;348:732-735.
28. c receptor) from Xenopus laevis dermal melanophores. J Biol Chem. 1993;25:19126-19133.
29. Sakurai T, Yanagisawa M, Masaki T. Molecular characterization of endothelin receptors. Trends Pharmacol Sci. 1992;13:103-108.
30. McMurdo L, Corder R, Thiemermann C, Vane JR. Incomplete inhibition of the pressor effects of endothelin-1 and related peptides in the anaesthetized rat with BQ-123 provides evidence for more than one vasoconstrictor receptor. Br J Pharmacol. 1993;108: 557-561.
31. Chakravarthy U, Gardiner TA, Anderson P, Archer DB, Trimble ER. The effect of endothelin-1 on the retinal microvascular pericyte. Microvasc Res. 1992; 43:241-254.
32. MacCumber MW, Ross CA, Glaser BM, Snyder SH. Endothelin: Visualization of mRNA by in situ hybridization provides evidence for local action. Proc Natl Acad Sci U S A. 1989;86:7285-7289.
33. Ramachandran E, Frank RN, Kennedy A. Effects of endothelin on cultured bovine retinal microvascular pericytes. Invent Ophthalmol Vis Sci. 1993;34:586-595.
34. B receptor agonist. Life Sci. 1993;53:PL111-PL115.
35. Meyer P, Flammer J, Luscher TF. Endothelium-dependent regulation of the ophthalmic microcirculation in the perfused porcine eye: role of nitric oxide and endothelins. Invest Ophthalmol Vis Sci. 1993;34:3614-3621.
36. Riva CE, Feke GT, Ben-Sira I. Fluorescein dye-dilution technique and retinal circulation. Am J Physiol. 1978;234:H315-H321.
37. Bulpitt CJ, Dollery CT. Estimation of retinal blood flow by measurement of mean circulation time. Cardiovasc Res. 1971;5:406-412.
38. Sakurai T, Yanagisawa M, Inoue A, et al. cDNA cloning, sequence analysis and tissue distribution of rat preproendothelin-1 mRNA. Biochem Biophys Res Comm. 1991;175:44-47.
39. Kohan DE, Padilla E. Osmolar regulation of endothelin-1 production by rat inner medullary collecting duct. J Clin Invest. 1993;91:1235-1240.
40. Hughes AK, Cline RC, Kohan DE. Alterations in renal endothelin-1 production in the spontaneously hypertensive rat. Hypertension. 1992;20:666-673.
41. Oliver FJ, de la Rubia G, Feener EP, et al. Stimulation of endothelin-1 gene expression by insulin in endothelial cells. J Biol Chem. 1991;266:23251-23256.
42. Kohan DE. Endothelin synthesis by rat inner medullary collecting duct cells. J Am Soc Nephrol. 1991;2:150-155.
43. Kohan DE. Endothelin synthesis by rabbit renal tubule cells. Am J Physiol. 1991;261:F221-F226.
44. Hughes A. A schematic eye for rat. Vision Res. 1979; 19:569-588.
45. McMahon EG, Palomo MA, Moore WM, McDonald JF, Stern MK. Phosphoramidon blocks the pressor activity of porcine big endothelin-1-(1-39) in vivo and conversion of big endothelin-1-(1-39) to endothelin-1-(1-21) in vitro. Proc Natl Acad Sci U S A. 1991; 88:703-707.
46. Ikegawa R, Matsumura Y, Tsukahara Y, Takaoka M, Morimoto S. Phosphoramidon inhibits the generation of endothelin-1 from exogenously applied big endothelin-1 in cultured vascular endothelial cells and smooth muscle cells. FEBS Lett. 1991;293:45-48.
47. Cummins DR, Bursell S-E, Clermont AC, Taggart JJ, King GL. The effect of intravitreal angiotensin II on retinal vascular flow. Invest Ophthalmol Vis Sci. 1994;35(Suppl. 4):1589.
48. Jan Danser AH, Derkx FHM, Admiraal PJJ, Deinum J, De Jong PTVM, Schalekamp MADH. Angiotensin levels in the eye. Invest Ophthalmol Vis Sci. 1994; 35:1008-1018.
49. Rockwood EJ, Fantes F, Davis EB, Anderson DR. The response of the retinal vasculature to angiotensin. Invest Ophthalmol Vis Sci. 1987;28:676-682.
50. Ferrari-Dileo G, Davis EB, Anderson DR. Angiotensin binding sites in bovine and human retinal blood vessels. Invest Ophthalmol Vis Sci. 1987;33:1747-1751.
51. Gilliland G, Perrin S, Blanchard K, Bunn HF. Analysis of cytokine mRNA and DNA: Detection and quantitation by competitive polymerase chain reaction. Proc Natl Acad Sci U S A. 1990;87:2725-2729.
52. Haeflinger IO, Flammer J, Luscher TF. Heterogeneity of endothelium-dependent regulation in ophthalmic and ciliary arteries. Invest Ophthalmol Vis Sci. 1993; 34:1722-1730.
53. Randall MD, Edwards DH, Griffith TM. Activities of endothelin-1 in the vascular network of the rabbit ear: A microangiographic study. Br J Pharmacol. 1990; 101:781-788.
54. Areceptor. Life Sci. 1992;50:247-255.
55. Lin HY, Kaji EH, Winkel GK, Ives HE, Lodish HF. Cloning and function expression of human endothelin-1 receptor cDNA. Proc Natl Acad Sci U S A. 1991;88:3185-3189.
56. Small KW, Stefansson E, Hatchell DL. Retinal blood flow in normal and diabetic dogs. Invest Ophthalmol Vis Sci. 1987;28:672-675.
57. Grunwald JE, Riva GE, Baine J, Bruckei AJ. Total retinal volumetric blood flow rate in diabetic patients with poor glycemic control. Invest Ophthalmol Vis Sci. 1992;33:356-363.
58. Tilton RG, Chang K, Pugliese G, Province DM, Kilo C, Williamson JR. Prevention of hemodynamic and vascular albumin filtration changes in diabetic rats by aldose reductase inhibitors. Diabetes. 1989;38:1258-1270.
59. Cringle SJ, Yu DY, Alder VA, Su EN. Retinal blood flow by hydrogen clearance polarography in the streptozotocin-induced diabetic rat. Invest Ophthalmol Vis Sci. 1993;34:1716-1721.
60. Masaki T, Kimura S, Yanagisawa M, Goto K. Molecular and cellular mechanism of endothelin regulation. Implications for vascular function. Circulation. 1991; 84:1457-1468.
61. Takahashi K, Suda K, Lam HC, Ghatei MA, Bloom SR. Endothelin-like immunoreactivity in rat models of diabetes mellitus. J Endocrinol. 1991;130:123-127.
62. Frank HJ, Levin ER, Hu RM, Pedram A. Insulin stimulates endothelin binding and action on cultured vascular smooth muscle cells. Endocrinology. 1993;133:1092-1097.
63. Yamauchi T, Ohnaka K, Takayanagi R, Umeda F, Nawata H. Enhanced secretion of endothelin-1 by elevated glucose levels from cultured bovine aortic endothelial cells. FEBS Lett. 1990;267:16-18.